Unilife Corporation announced its financial results for the fiscal fourth quarter and full fiscal year ending June 30, 2015.
Article continues below
Revenue for the fourth quarter of fiscal year 2015 and for the fiscal year 2015 was $3.5 million and $13.2 million, respectively. This compares to revenue in the fourth quarter of the fiscal year 2014 and for the fiscal year 2014 of $6.5 million and $14.7 million, respectively.
Cash receipts from customers for the fiscal year 2015 was $22.7 million compared to cash receipts from customers of $23.7 million for the fiscal year 2014. Deferred revenue increased to $22.5 million as of June 30, 2015, up from $13.3 million on June 30, 2014.
Research and development expense for the fourth quarter of fiscal year 2015 and for the fiscal year 2015 was $15.5 million and $48.7 million, respectively, excluding share-based compensation and depreciation expense.
This compares to research and development expense in the fourth quarter of the fiscal year 2014 and for the fiscal year 2014 of $11.3 million and $31 million, respectively, excluding share-based compensation expense and depreciation expense.
Selling, general and administrative expense for the fourth quarter of fiscal year 2015 and for the fiscal year 2015 was $7.0 million and $28.1 million, respectively, excluding share-based compensation and depreciation expense.
This compares to selling, general and administrative expense in the fourth quarter of the fiscal year 2014 and for the fiscal year 2014 of $7.2 million and $22.7 million, respectively excluding share-based compensation expense and depreciation expense.
The Company's net loss for the fiscal year of 2015 was $90.8 million, or $0.81 per share, compared to a net loss of $57.9 million, or $0.59 per share, for fiscal year 2014.
Adjusted net loss for the full fiscal year of 2015 was $63.5 million, or $0.57 per share, compared to $38.8 million or $0.40 per share for the prior year. Adjusted net loss excludes non-cash share-based compensation expense, depreciation and amortization, interest expense and the change in fair value of financial instruments.
Unilife had $14.7 million in total cash and cash equivalents, including restricted cash of $2.4 million, as of June 30, 2015. ■